Advertisement
Screener

Surrozen, Inc./DE (SRZN) Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

2.2 / 5 stars · 17/39 Roast Me

Surrozen, Inc./DE Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount

Surrozen, Inc./DE (SRZN) reported Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount of 21.97 million shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.

Financial Statements › Income Statement › Earnings Per Share

us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount · last filed 2026-08-06

  • Surrozen, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2026-03-31 was 22.18M shares, a 4.85% increase year-over-year.
  • Surrozen, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2025-03-31 was 21.16M shares, a 2716.91% increase year-over-year.
  • Surrozen, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2024-03-31 was 751.00K shares, a 88.00% decline year-over-year.
  • Surrozen, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for the quarter ending 2023-03-31 was 6.26M shares, a 58089.94% increase year-over-year.
  • Surrozen, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for fiscal 2025 was 21.09M shares, a 73.63% increase from fiscal 2024.
  • Surrozen, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for fiscal 2024 was 12.14M shares, a 1519799.87% increase from fiscal 2023.
  • Surrozen, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for fiscal 2023 was 799.00 shares, a 20.69% increase from fiscal 2022.
  • Surrozen, Inc./DE antidilutive securities excluded from computation of earnings per share, amount for fiscal 2022 was 662.00 shares, a 99.99% decline from fiscal 2021.
Period endAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 3 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 6 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 9 month as first filedAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 monthAntidilutive Securities Excluded from Computation of Earnings Per Share, Amount 12 month as first filed
2026-06-3021.97M shares
10-Q · filed 2026-08-06
2026-03-3122.18M shares
10-Q · filed 2026-05-06
2025-12-3121.09M shares
10-K · filed 2026-03-23
2025-09-3021.50M shares
10-Q · filed 2025-11-07
2025-06-3021.48M shares
10-Q · filed 2026-08-06
2025-03-3121.16M shares
10-Q · filed 2026-05-06
8.40M shares
10-Q · filed 2025-05-09
2024-12-3112.14M shares
10-K · filed 2026-03-23
12.14K shares
10-K · filed 2025-03-31
2024-09-3012.16M shares
10-Q · filed 2025-11-07
2024-06-3017.73M shares
10-Q · filed 2025-08-08
2024-03-31751.00K shares
10-Q · filed 2025-05-09
6.26M shares
10-Q · filed 2024-05-08
2023-12-31799.00 shares
10-K · filed 2025-03-31
2023-09-30806.00K shares
10-Q · filed 2024-11-06
12.07K shares
10-Q · filed 2023-11-08
2023-06-306.25M shares
10-Q · filed 2024-08-12
10.99K shares
10-Q · filed 2023-08-09
2023-03-316.26M shares
10-Q · filed 2024-05-08
11.14K shares
10-Q · filed 2023-05-10
2022-12-31662.00 shares
10-K · filed 2024-04-10
9.93M shares
10-K · filed 2023-03-31
2022-09-3011.18K shares
10-Q · filed 2023-11-08
11.18M shares
10-Q · filed 2022-11-14
2022-06-3010.89K shares
10-Q · filed 2023-08-09
10.89M shares
10-Q · filed 2022-08-11
2022-03-3110.75K shares
10-Q · filed 2023-05-10
5.34M shares
10-Q · filed 2022-05-11
2021-12-319.25M shares
10-K · filed 2023-03-31
9.25M shares
10-K · filed 2022-03-28
2021-09-309.20M shares
10-Q · filed 2022-11-14
9.20M shares
10-Q · filed 2021-11-15
2021-06-301.78M shares
10-Q · filed 2022-08-11
2021-03-311.77M shares
10-Q · filed 2022-05-11
2020-12-311.22M shares
10-K · filed 2022-03-28
2020-09-301.05M shares
10-Q · filed 2021-11-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
Zura Bio Ltd (ZURA)$0.398B-6.56
AGENUS INC (AGEN)United States$0.383B1.41
Scribe Therapeutics, Inc. (SCTX)United States$0.410B
C4 Therapeutics, Inc. (CCCC)United States$0.373B-5.65
FENNEC PHARMACEUTICALS INC. (FENC)United States$0.371B-115.85
Editas Medicine, Inc. (EDIT)United States$0.424B-4.29
Artiva Biotherapeutics, Inc. (ARTV)United States$0.367B
Cabaletta Bio, Inc. (CABA)United States$0.365B-2.81
Kyverna Therapeutics, Inc. (KYTX)United States$0.434B-3.60
Eikon Therapeutics, Inc. (EIKN)United States$0.446B